ncpe annual training day - march 10th 2016 - derick mitchell
TRANSCRIPT
March 11th, 2016
PATIENTS – SCIENCE – INDUSTRY
NCPE Training Course on HTA
Derick Mitchell
Patient Involvement in Healthcare Decision-making
Why?
Who?
When?
How?
IPPOSI? Who?IPPOSI
Mission
We expedite development of and patient access to innovative therapies
Unique partnership of Patient Groups, Industry and Science
Priorities
• Bring a patient perspective to clinical research, connected health, health economics
• Actively influence policy that impacts on research + access to innovative therapies
“Putting patients in policy and medicines development”
Partnership Approach
Other Stakeholders
Patient Experts
• Encourage open, constructive dialogue and interaction
• Highlight value that patients can bring
• Develop new opportunities for patients to influence decision-making
IPPOSI Funding
• Grant from Department of Health
(via Health Research Board)
• Industry membership fee
Goals for patient involvement in HTA?
• Democratic
• Scientific
• Instrumental
• Developmental
IPPOSI Partnership with HIQA + NCPE
• HIQA have patient involvement on the advisory board of individual HTAs
• Annual HTA Training for patients through IPPOSI
• List of products under NCPE rapid review available on IPPOSI website
• Irish patient groups exploring measuring patient outcomes with the NCPE
Annual HTA & Decision Training
2016:
“incorporating the patient perspective”
Submission of patient org information
Other jurisdictions?
• European Patients Forum Survey
• SMC• Patient Group Partners
• Submission Form• Patient Org. Registration Form• Guidance (Good Example)
• Public Involvement Network Advisory Group
Values and Quality Standards for PPI
• HIQA• Guidelines for Stakeholder
Engagement in HTA
• EUnetHTA• Stakeholder Forum
• HTAi• Vision: that patient and
citizen perspectives improve HTA
http://www.htai.org/interest-groups/patient-and-citizen-involvement/pcig-resources/hta-resources.html
Irish Educational Platform
• John Dowling, Men Against Cancer
• Caitriona Dunne, Fighting Blindness
• Joan Jordan, MS Ireland
• Katie Murphy, CF Ireland
• Rachel Lynch, FibroIreland
• Damien Peelo, COPD Support Ireland
• Julie Power, Vasculitis Ireland Awareness
• Sharon Thompson, Rare Dis. + Palliative care
8 Irish Trainees
The project is receiving support from the Innovative Medicines Initiative Joint Undertaking under grant agreement n° 115334, resources of which are composed of financial contribution from the European Union's Seventh Framework Programme (FP7/2007-2013) and EFPIA companies.
Why?, Who?, When?, How?
EXAMPLES:
• In clinical trial methodology / outcomes
• Incorporate patient preferences in QALY
• Adjusting clinical / review criteria
• In between NCPE recommendation + HSE decision
Take Home Messages
•Develop clear policies for PPI
• Early & Ongoing Involvement
•Need Education/Training for all
@IPPOSI
www.ipposi.ie